Over 379.3 million Covid-19 vaccine doses provided to states, UTs

The new phase of universalisation of COVID-19 vaccination commenced from June 21, 2021.

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
ANI General News
2 min read Last Updated : Jul 08 2021 | 5:02 PM IST

The Ministry of Health and Family Welfare on Thursday informed that more than 37.93 crore COVID-19 vaccine doses have been provided to states and UTs so far.

"More than 37.93 crore (37,93,56,790) vaccine doses have been provided to states/UTs so far, through all sources and a further 23,80,000 doses are in the pipeline," the ministry said.

Of this, the total consumption including wastages is 36,09,69,128 doses (as per data available at 8 am today).

It further said 1,83,87,662 balance and unutilised COVID vaccine doses are still available with the states and UTs and private hospitals to be administered.

The new phase of universalisation of COVID-19 vaccination commenced from June 21, 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to states and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the states and UTs by providing them COVID vaccines free of cost. In the new phase of the universalisation of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to states and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 08 2021 | 5:01 PM IST

Next Story